{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:56:42Z","timestamp":1790758602283,"version":"4.1.0"},"reference-count":48,"publisher":"Harborside Press, LLC","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:<\/jats:bold> Prostate cancer clinical stage T2 (cT2) subclassifications, as determined by digital rectal examination (DRE), are a historic method of staging prostate cancer. However, given the potential discomfort associated with prostate examination and the wide availability of other prognostic tests, the necessity of DRE is uncertain. This study sought to determine the prognostic value of the prostate cancer cT2 subclassifications in a contemporary cohort of patients. <jats:bold>Methods:<\/jats:bold> The National Cancer Database was used to identify a cohort of men with high-risk clinical T2N0M0 prostate cancer treated with external-beam radiotherapy and androgen deprivation therapies \u00b1 surgery from 2004 to 2010. We assessed overall survival from a landmark time of 10 months using Kaplan-Meier and log-rank test analysis. A multivariate proportional hazards model was used to estimate the simultaneous effects of multiple factors, including cT2 subclassification and other well-established prognostic indicators of overall survival in prostate cancer. <jats:bold>Results:<\/jats:bold> A total of 5,291 men were included in the final analysis, with a median follow-up of 5.4 years. The cT2a, cT2b, and cT2c subclassifications demonstrated increasing hazard ratios of 1.00 (reference), 1.25 (95% CI, 1.07\u20131.45; <jats:italic>P<\/jats:italic>=.0046), and 1.43 (95% CI, 1.25\u20131.63; <jats:italic>P<\/jats:italic>&lt;.0001), respectively, reflecting a higher probability of death with each incremental increase in cT2 subclassification. This finding was independent of other known prognostic variables on multivariate analysis. <jats:bold>Conclusions:<\/jats:bold> Results show that cT2 subclassifications had independent prognostic value in a large and contemporary cohort of men. cT2 classification remains an important, low-cost prognostic tool for men with prostatic adenocarcinoma. The clinical relevance of this test should be appreciated and accounted for by providers treating prostate adenocarcinoma.<\/jats:p>","DOI":"10.6004\/jnccn.2018.7278","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T19:55:03Z","timestamp":1563479703000},"page":"829-837","source":"Crossref","is-referenced-by-count":15,"title":["Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review"],"prefix":"10.6004","volume":"17","author":[{"given":"Jenna F.","family":"Borkenhagen","sequence":"first","affiliation":[{"name":"aDepartments of Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eastwood","sequence":"additional","affiliation":[{"name":"bBiostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kilari","sequence":"additional","affiliation":[{"name":"cHematology-Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"See","sequence":"additional","affiliation":[{"name":"dUrology, Medical College of Wisconsin, Milwaukee, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Van Wickle","sequence":"additional","affiliation":[{"name":"aDepartments of Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen A.","family":"Lawton","sequence":"additional","affiliation":[{"name":"aDepartments of Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Hall","sequence":"additional","affiliation":[{"name":"aDepartments of Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref61","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2009.07.020","article-title":"Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy","volume":"182","author":"Kordan","year":"2009","journal-title":"J Urol"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2016.05.016","article-title":"Modification of the pT2 substage classification in prostate adenocarcinoma","volume":"56","author":"Ettel","year":"2016","journal-title":"Hum Pathol"},{"key":"ref161","first-page":"3","article-title":"Finding the wolf in sheep\u2019s clothing: the 4Kscore is a novel blood test that can accurately identify the risk of aggressive prostate cancer","volume":"17","author":"Punnen","year":"2015","journal-title":"Rev Urol"},{"key":"ref281","first-page":"10","article-title":"1992 staging system for prostate cancer","volume":"11","author":"Montie","year":"1993","journal-title":"Semin Urol"},{"key":"ref11","article-title":"Guidelines in Version Accessed To view the most recent version visitNCCN org","volume":"22","author":"MohlerJL","year":"2018","journal-title":"Clinical Practice Oncology Prostate Cancer"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.urology.2007.07.010","article-title":"Are doctors examining prostates in university hospital?","volume":"70","author":"Lim","year":"2007","journal-title":"Urology"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1097-0142(19920701)70:1+<269::AID-CNCR2820701313>3.0.CO;2-W","article-title":"Critical assessment of prostate cancer staging","volume":"70","author":"Graham","year":"1992","journal-title":"Cancer"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0090-4295(95)96812-1","article-title":"Interexaminer variability of digital rectal examination in detecting prostate cancer","volume":"45","author":"Smith","year":"1995","journal-title":"Urology"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/pcan.2013.46","article-title":"Very-high-risk localized prostate cancer: definition and outcomes","volume":"17","author":"Sundi","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archinte.164.3.313","article-title":"Underutilization of digital rectal examination when screening for prostate cancer","volume":"164","author":"Murthy","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/01.ju.0000181224.95276.82","article-title":"Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer","volume":"174","author":"Mullerad","year":"2005","journal-title":"J Urol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00432-015-2093-0","article-title":"Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach","volume":"142","author":"Lee","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref241","volume-title":"Clinical Radiation Oncology","author":"Gunderson","year":"2015"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjmed.2013.08.012","article-title":"\u2018Race\u2019 and prostate cancer mortality in equal-access healthcare systems","volume":"126","author":"Graham-Steed","year":"2013","journal-title":"Am J Med"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/03007995.2016.1254608","article-title":"Re: Cui T, Kovell RC, Terlecki RP. Is it time to abandon the digital rectal examination? Lessons from the PLCO cancer screening trial and peer-reviewed literature. Curr Med Res Opin 2016;32:1\u20137","volume":"33","author":"Nyitray","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/iju.13119","article-title":"Multiparametric magnetic resonance imaging: current role in prostate cancer management","volume":"23","author":"Ueno","year":"2016","journal-title":"Int J Urol"},{"key":"ref271","article-title":"Guidelines in Version Accessed To view the most recent version visitNCCN org","volume":"22","author":"MohlerJL","year":"2018","journal-title":"Clinical Practice Oncology Prostate Cancer"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjmed.2013.08.012","article-title":"\u2018Race\u2019 and prostate cancer mortality in equal-access healthcare systems","volume":"126","author":"Graham-Steed","year":"2013","journal-title":"Am J Med"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/pgmj.2006.054825","article-title":"Digital rectal examination: national survey of undergraduate medical training in Ireland","volume":"83","author":"Fitzgerald","year":"2007","journal-title":"Postgrad Med J"},{"key":"ref401","first-page":"1","article-title":"of Surgeons National https www facs org quality programs cancer ncdb Accessed","author":"May","year":"2017","journal-title":"American College Cancer Database"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/01.ju.0000181224.95276.82","article-title":"Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer","volume":"174","author":"Mullerad","year":"2005","journal-title":"J Urol"},{"key":"ref21","first-page":"10","article-title":"1992 staging system for prostate cancer","volume":"11","author":"Montie","year":"1993","journal-title":"Semin Urol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0090-4295(95)96812-1","article-title":"Interexaminer variability of digital rectal examination in detecting prostate cancer","volume":"45","author":"Smith","year":"1995","journal-title":"Urology"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.urolonc.2016.03.001","article-title":"Prostate cancer risk stratification with magnetic resonance imaging","volume":"34","author":"Felker","year":"2016","journal-title":"Urol Oncol"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archinte.164.3.313","article-title":"Underutilization of digital rectal examination when screening for prostate cancer","volume":"164","author":"Murthy","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref501","volume-title":"Clinical Radiation Oncology","author":"Gunderson","year":"2015"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00345-016-1981-5","article-title":"Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy","volume":"35","author":"Lebacle","year":"2017","journal-title":"World J Urol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/03007995.2016.1254608","article-title":"Re: Cui T, Kovell RC, Terlecki RP. Is it time to abandon the digital rectal examination? Lessons from the PLCO cancer screening trial and peer-reviewed literature. Curr Med Res Opin 2016;32:1\u20137","volume":"33","author":"Nyitray","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2012.11.014","article-title":"Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer","volume":"65","author":"Leyten","year":"2014","journal-title":"Eur Urol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2016.05.016","article-title":"Modification of the pT2 substage classification in prostate adenocarcinoma","volume":"56","author":"Ettel","year":"2016","journal-title":"Hum Pathol"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1200\/JCO.2002.08.123","article-title":"Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?","volume":"20","author":"Cagiannos","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/iju.13119","article-title":"Multiparametric magnetic resonance imaging: current role in prostate cancer management","volume":"23","author":"Ueno","year":"2016","journal-title":"Int J Urol"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1200\/JCO.2002.08.123","article-title":"Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?","volume":"20","author":"Cagiannos","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.urology.2007.07.010","article-title":"Are doctors examining prostates in university hospital?","volume":"70","author":"Lim","year":"2007","journal-title":"Urology"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.urolonc.2016.03.001","article-title":"Prostate cancer risk stratification with magnetic resonance imaging","volume":"34","author":"Felker","year":"2016","journal-title":"Urol Oncol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/pcan.2013.46","article-title":"Very-high-risk localized prostate cancer: definition and outcomes","volume":"17","author":"Sundi","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2559.2011.04025.x","article-title":"Staging of prostate cancer","volume":"60","author":"Cheng","year":"2012","journal-title":"Histopathology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1097-0142(19920701)70:1+<269::AID-CNCR2820701313>3.0.CO;2-W","article-title":"Critical assessment of prostate cancer staging","volume":"70","author":"Graham","year":"1992","journal-title":"Cancer"},{"key":"ref421","first-page":"3","article-title":"Finding the wolf in sheep\u2019s clothing: the 4Kscore is a novel blood test that can accurately identify the risk of aggressive prostate cancer","volume":"17","author":"Punnen","year":"2015","journal-title":"Rev Urol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2559.2011.04025.x","article-title":"Staging of prostate cancer","volume":"60","author":"Cheng","year":"2012","journal-title":"Histopathology"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00345-016-1981-5","article-title":"Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy","volume":"35","author":"Lebacle","year":"2017","journal-title":"World J Urol"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2012.11.014","article-title":"Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer","volume":"65","author":"Leyten","year":"2014","journal-title":"Eur Urol"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2009.07.020","article-title":"Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy","volume":"182","author":"Kordan","year":"2009","journal-title":"J Urol"},{"key":"ref141","first-page":"1","article-title":"of Surgeons National https www facs org quality programs cancer ncdb Accessed","author":"May","year":"2017","journal-title":"American College Cancer Database"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/pgmj.2006.054825","article-title":"Digital rectal examination: national survey of undergraduate medical training in Ireland","volume":"83","author":"Fitzgerald","year":"2007","journal-title":"Postgrad Med J"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00432-015-2093-0","article-title":"Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach","volume":"142","author":"Lee","year":"2016","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/17\/7\/article-p829.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T04:05:23Z","timestamp":1564891523000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/17\/7\/article-p829.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":48,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2018.7278","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}